Biallelic or compound heterozygosity of the G396D and Y179C mutations in MUTYH, which are carried by around 1%–2% of the UK population, confers a CRC risk comparable to that seen in carriers of germline MMR mutations [35]. Here, MRC1 is linked to colorectal carcinoma.